Wesfarmers and Sigma Pharma now
vying for control of API ( Australian Pharmaceutical Industries) nearly $800m.
This is less than our Teva deal debacle.
I cannot understand how Mayne with its
facilities and supposedly expert staff have
not seemed to have done any unique or
radical R and D of some groundbreaking
product after all these years with SR at the
helm. Surely there must be something Scientific
genius board could have pursued. We seem
to just buy other companies products. All Richards seems to do is chase revenue mainly
at losses but enough to maintain $100m +
administration expenses each year.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.07 |
Change
0.050(1.00%) |
Mkt cap ! $411.9M | |||
| Open | High | Low | Value | Volume |
| $5.00 | $5.14 | $4.94 | $712.4K | 141.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1059 | $5.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.13 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |